Advancement of Copaxone—regulatory. . . 10% 70% 7.0%
Advancement of Copaxone—development . . 10% 70% 7.0%
I find this "assessment" somewhat bothering in that they are not all that bullish on their own efforts on m-Copaxone and where things stand today. Anyone else draw the same inference?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.